Maternal serum levels of IGFBP-4 in early pregnancy have been reported to be significantly altered in cases with later development of fetal growth restriction (FGR) when compared to normal pregnancies, thus confirming its function as an enhancer of placental growth and development42. This evidence concerns the gene IGFBP4 and fetal growth restriction.